When a cancer center decides to add proton therapy to its radiation oncology department, it makes a long-term commitment to therapeutic innovation and high-quality patient care. A question remains essential: how to select the best proton therapy equipment provider, to ensure optimal installation and best-in-class performance throughout the system’s lifecycle?​

Does IBA support radiation oncology centers in improving their proton therapy journey? ​

How can we improve the environmental impact of cancer care in the growing context of climate change and worldwide ecological issues?
 

In proton therapy, the design of the system significantly influences key beam parameters, and can have a direct impact on patient care. Thus, it is important to understand beam quality's role in radiotherapy and cancer treatment.​

In the ever-evolving landscape of cancer treatment, can the future of cancer care be shaped by proton arc therapy with DynamicARC^®*?  ​

In the ever-evolving landscape of cancer treatment, how can cancer centers ensure they provide the most advanced proton therapy treatment and highest-quality patient care?

As a hospital executive, head of the radiotherapy department, radiation oncologist, medical physicist or radiotherapist, you may wonder if adding proton therapy treatment to your radiation oncology department can increase your hospital’s attractivity, improve cancer patient experience, and contribute to talent attraction and retention. ​

The journey of proton therapy for cancer treatment has been transformative, particularly at Massachusetts General Hospital (MGH). The discussion led by Dr. Helen Shih and Dr. Anthony Zietman highlights the advancements in proton therapy at MGH since its initial installation in the 1960s, and the excitement of the first restoration of a proton therapy system. Dr. Shih is the medical director of the Proton Therapy Center, specializing in brain and ocular tumors, while Dr. Zietman, former chief of Radiation Oncology, specializes in genitourinary (GU) oncology and has been using proton therapy since for almost four decades.

Proton therapy represents a significant advancement in radiation oncology. In this article, Dr. Craig Stevens, Chair of Radiation Oncology at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, discusses the evolution and benefits of their ProteusONE system installed in 2017.  

DynamicARC* represents a pivotal breakthrough in radiation therapy and in cancer treatment. In this blog, Dr. Craig Stevens, Professor and Chair of the Department of Radiation Oncology at William Beaumont Hospital, part of the Corewell Health System, emphasizes to what extent DynamicARC is key to the future of radiation therapy with protons, enabling a paradigm shift in cancer treatment.